Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

OPRX

OptimizeRx Corp

Dec 13 • 04:00PM ET

4.99

Dollar change +0.06
Percentage change 1.22	%

Healthcare • Health Information Services • USA • NASD

Peers: TDOC VEEV HSTM GDRX PEGA OTLK HIMX HUT DHX

| Held by: VTI IWM VXF IWO VTWO DFAT DFAS IWC VTWG JFWD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.33	Insider Own	13.28%	Shs Outstand	18.33M	Perf Week	-6.90%
Market Cap	93.04M	Forward P/E	14.56	EPS next Y	0.34	Insider Trans	0.00%	Shs Float	15.97M	Perf Month	-18.86%
Income	-24.17M	PEG	-	EPS next Q	0.25	Inst Own	66.25%	Short Float	6.27%	Perf Quarter	-35.45%
Sales	88.18M	P/S	1.06	EPS this Y	8.79%	Inst Trans	-9.33%	Short Ratio	4.09	Perf Half Y	-54.64%
Book/sh	6.25	P/B	0.80	EPS next Y	21.19%	ROA	-16.72%	Short Interest	1.00M	Perf Year	-50.89%
Cash/sh	0.87	P/C	5.77	EPS next 5Y	-	ROE	-20.97%	52W Range	3.78 - 16.65	Perf YTD	-65.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-16.33%	52W High	-70.02%	Beta	1.35
Dividend TTM	-	Quick Ratio	3.23	Sales past 5Y	30.00%	Gross Margin	57.79%	52W Low	32.01%	ATR (14)	0.48
Dividend Ex-Date	-	Current Ratio	3.23	EPS Y/Y TTM	-63.50%	Oper. Margin	-8.59%	RSI (14)	45.86	Volatility	10.49% 9.96%
Employees	136	Debt/Eq	0.31	Sales Y/Y TTM	40.40%	Profit Margin	-27.41%	Recom	1.00	Target Price	11.17
Option/Short	Yes / Yes	LT Debt/Eq	0.29	EPS Q/Q	-189.14%	Payout	-	Rel Volume	1.73	Prev Close	4.93
Sales Surprise	-14.73%	EPS Surprise	103.39%	Sales Q/Q	30.48%	Earnings	Nov 13 AMC	Avg Volume	244.96K	Price	4.99
SMA20	1.29%	SMA50	-10.85%	SMA200	-45.66%	Trades		Volume	423,029	Change	1.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-25-24	Resumed	B. Riley Securities	Buy	$18.50
Apr-04-24	Initiated	JMP Securities	Mkt Outperform	$15
Jan-03-24	Initiated	Barclays	Equal Weight	$15
Feb-02-23	Resumed	B. Riley Securities	Buy	$30
Nov-01-22	Initiated	Stifel	Buy	$19
Jul-15-22	Initiated	SVB Leerink	Outperform	$38
Oct-18-21	Resumed	B. Riley Securities	Buy	$102
Apr-13-21	Initiated	RBC Capital Mkts	Outperform	$65
Jan-03-19	Initiated	William Blair	Outperform

Nov-18-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +9.80%
Nov-14-24 02:15AM	OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ... (GuruFocus.com) -33.98%
Nov-13-24 05:35PM	OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates (Zacks) +5.31%
04:05PM	OptimizeRx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 09:12AM	OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? (Zacks)
07:30AM	Loading…
Oct-31-24 07:30AM	OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET (GlobeNewswire)
Oct-03-24 04:25AM	OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? (Zacks)
Sep-10-24 07:30AM	OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value (GlobeNewswire)
Sep-09-24 12:00PM	OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences (GlobeNewswire)
Sep-04-24 09:35AM	Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 06:25PM	OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates (Zacks) +6.88% -5.31%
04:05PM	OptimizeRx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 10:01AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-24 07:30AM	OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET (GlobeNewswire)
Jul-23-24 07:30AM	OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation (GlobeNewswire)
07:30AM	Loading…
Jul-15-24 07:30AM	OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients (GlobeNewswire)
Jun-20-24 07:30AM	New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations (GlobeNewswire)
May-14-24 08:56PM	OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +25.67%
04:01PM	OptimizeRx Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 09:55AM	Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect? (Zacks)
May-06-24 04:30PM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-26-24 07:30AM	OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM	After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
Apr-22-24 09:35AM	Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) (Zacks)
Apr-18-24 07:30AM	OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-16-24 07:00AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Apr-11-24 07:30AM	OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row (GlobeNewswire)
Apr-06-24 06:00AM	7 Top Undervalued Stocks Primed for a Multibagger Recovery (InvestorPlace)
Apr-01-24 03:02PM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.01%
Mar-28-24 09:54PM	OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 (InvestorPlace)
07:30AM	Loading…
Mar-25-24 07:30AM	OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET (GlobeNewswire)
Mar-11-24 04:30PM	OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 (GlobeNewswire) -14.12%
Mar-04-24 03:51PM	OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort (GlobeNewswire)
Feb-21-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Jan-09-24 07:30AM	OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update (GlobeNewswire) +13.85%
Dec-26-23 06:19AM	Should You Exit OptimizeRx Corp. (OPRX)? (Insider Monkey)
Dec-18-23 07:30AM	OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco (GlobeNewswire) +5.98%
Dec-11-23 12:00PM	OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know (Zacks)
Nov-21-23 12:20PM	Why OptimizeRx Corp. (OPRX) Might be Well Poised for a Surge (Zacks)
Nov-20-23 09:55AM	How Much Upside is Left in OptimizeRx Corp. (OPRX)? Wall Street Analysts Think 47.72% (Zacks)
Nov-13-23 11:38AM	OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 02:17AM	Q3 2023 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 08:17AM	OptimizeRx Corp (OPRX) Reports Q3 2023 Earnings, Raises 2023 Guidance and Introduces 2024 Guidance (GuruFocus.com) +15.31%
07:00AM	OptimizeRx Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 10:00AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-25-23 07:30AM	OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET (GlobeNewswire) -5.14%
Oct-13-23 03:59AM	OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains? (Zacks) +5.07%
Oct-12-23 07:00AM	OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers (GlobeNewswire) +13.01%
Sep-26-23 08:00AM	OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform (GlobeNewswire)
Aug-24-23 08:00AM	OptimizeRx Expands AI Powered Omnichannel Platform (GlobeNewswire)
Aug-14-23 04:01PM	OptimizeRx Reports Second Quarter 2023 Financial Results (GlobeNewswire) -27.76%
Aug-10-23 06:57AM	Positive Signs As Multiple Insiders Buy OptimizeRx Stock (Simply Wall St.)
Jul-31-23 08:01AM	OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET (GlobeNewswire)
Jun-30-23 10:52AM	OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst institutional investors who own 85% (Simply Wall St.)
Jun-20-23 08:00AM	LifeMD Appoints William J. Febbo to its Board of Directors (GlobeNewswire)
May-24-23 07:30AM	OptimizeRxs CEO Provides 2023 Midyear Strategic Update (GlobeNewswire) +11.70%
May-23-23 07:51PM	Down More Than 50%: These 3 Beaten-Down Stocks Could Stage a Strong Rebound, Analysts Say (TipRanks)
May-18-23 09:00AM	Revenues Tell The Story For OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
08:01AM	OptimizeRxs Karina Castagna Named One of the 2023 PM360 ELITE 100 (GlobeNewswire)
May-15-23 08:00AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-23 05:15PM	OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.46%
04:01PM	OptimizeRx Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 06:38AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 114% gain (Simply Wall St.)
May-02-23 08:00AM	Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance (GlobeNewswire)
Apr-26-23 08:00AM	OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET (GlobeNewswire)
Apr-17-23 10:38AM	Should You Think About Buying OptimizeRx Corporation (NASDAQ:OPRX) Now? (Simply Wall St.)
Apr-04-23 08:01AM	OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Apr-02-23 08:55AM	A Look At The Intrinsic Value Of OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
Mar-29-23 09:20AM	Financial Times Ranks OptimizeRx Amongst The Americas Fastest Growing Companies for the Fourth Consecutive Year (GlobeNewswire)
Mar-15-23 03:18AM	OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock? (Zacks)
Mar-14-23 07:30AM	OptimizeRx Authorizes $15 Million Share Repurchase Program (GlobeNewswire) +7.18%
Mar-12-23 08:40AM	Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Mar-11-23 07:13AM	Analysts Have Lowered Expectations For OptimizeRx Corporation (NASDAQ:OPRX) After Its Latest Results (Simply Wall St.)
Mar-10-23 02:39AM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.78%
Mar-09-23 09:06AM	Q4 2022 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents) -11.64%
08:01AM	OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients (GlobeNewswire)
Mar-08-23 05:25PM	OptimizeRx Corp. (OPRX) Q4 Earnings Beat Estimates (Zacks)
04:01PM	OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 06:56PM	Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) -10.43%
05:02AM	Great news for OptimizeRx Corporation (NASDAQ:OPRX): Insiders acquired stock in large numbers last year (Simply Wall St.)
Mar-02-23 10:54AM	Should You Buy OptimizeRx (OPRX) Ahead of Earnings? (Zacks)
10:00AM	Oracle (ORCL) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-23-23 08:00AM	OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET (GlobeNewswire) +5.15%
Feb-16-23 10:01AM	OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
Feb-09-23 08:30AM	OptimizeRxs Karina Castagna Named to MM+Ms 40 Under 40 List of the Medical Marketing Industrys Brightest Young Stars (GlobeNewswire)
Jan-21-23 09:12AM	With 86% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big guns (Simply Wall St.)
Jan-05-23 06:01AM	Strength Seen in OptimizeRx Corp. (OPRX): Can Its 10.1% Jump Turn into More Strength? (Zacks)
Jan-04-23 07:30AM	OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference (GlobeNewswire) +10.05%
Nov-28-22 09:31AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-14-22 10:44AM	Heres Why Artisan Partners Exited its Position in OptimizeRx Corporation (OPRX) (Insider Monkey)
Nov-10-22 05:58AM	OptimizeRx Third Quarter 2022 Earnings: EPS Beats Expectations (Simply Wall St.) +14.58%
Nov-08-22 05:35PM	OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates (Zacks) +22.38%
04:01PM	OptimizeRx Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 06:39AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 228% gain (Simply Wall St.)
Oct-24-22 03:53PM	Top 10 Small-Cap Stocks With Highest Upside Potential (Insider Monkey)
Oct-20-22 09:00AM	OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event (GlobeNewswire)
Oct-19-22 04:05PM	OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET (GlobeNewswire)
Oct-11-22 08:00AM	OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution (GlobeNewswire)

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Odence-Ford Marion	General Counsel and CCO	Nov 08 '24	Option Exercise	0.00	1,785	0	24,980	Nov 12 09:37 AM
Stelmakh Edward	CFO/COO	Oct 11 '24	Option Exercise	0.00	8,222	0	35,432	Oct 15 04:53 PM
Stelmakh Edward	CFO/COO	Oct 03 '24	Option Exercise	0.00	16,622	0	31,387	Oct 07 09:30 PM
Odence-Ford Marion	General Counsel and CCO	Oct 03 '24	Option Exercise	0.00	6,649	0	25,147	Oct 07 09:26 PM
Silvestro Stephen L	Chief Commercial Officer	Oct 03 '24	Option Exercise	0.00	6,649	0	79,495	Oct 07 09:24 PM
Besch Doug	Chief Product Officer	Oct 03 '24	Option Exercise	0.00	3,324	0	11,172	Oct 07 09:24 PM
FEBBO WILLIAM J	CEO	Apr 18 '24	Option Exercise	0.00	28,895	0	582,035	Jun 12 11:41 AM
Spangler Patrick D	Director	Jun 05 '24	Option Exercise	0.00	10,061	0	32,181	Jun 11 05:50 PM
Vos Ellen O'Connor	Director	Jun 05 '24	Option Exercise	0.00	10,061	0	49,488	Jun 11 05:49 PM
WASSON GREGORY D	Director	Jun 05 '24	Option Exercise	0.00	10,061	0	34,029	Jun 11 05:48 PM
HALAS GUS D	Director	Jun 05 '24	Option Exercise	0.00	10,061	0	80,926	Jun 11 05:48 PM
Lang James Paul	Director	Jun 05 '24	Option Exercise	0.00	10,061	0	54,758	Jun 11 05:46 PM
Silvestro Stephen L	Chief Commercial Officer	May 02 '24	Option Exercise	0.00	90,000	0	108,261	May 06 09:35 PM
Silvestro Stephen L	Chief Commercial Officer	Mar 01 '24	Option Exercise	0.00	1,927	0	6,624	Mar 06 04:20 PM
Odence-Ford Marion	General Counsel and CCO	Mar 01 '24	Option Exercise	0.00	771	0	14,499	Mar 06 04:19 PM
Odence-Ford Marion	General Counsel and CCO	Feb 11 '24	Option Exercise	0.00	4,000	0	15,114	Feb 13 06:16 PM
FEBBO WILLIAM J	CEO	Jan 09 '24	Option Exercise	0.00	9,628	0	481,028	Jan 18 05:56 PM
Odence-Ford Marion	General Counsel and CCO	Jan 09 '24	Sale	15.19	4,000	60,751	11,114	Jan 11 05:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPRX

OptimizeRx Corp

Upgrade your FINVIZ experience